Illumina INC:1107104 [21-002812] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550. These kits are…
Ended Awarded
- Contract number
- 75N92B21F02003
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $170,009
Award facts
- Contract value 100% obligated
- $170,008.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
About this award
Illumina, Inc. was awarded a firm fixed-price delivery order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to provide sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing instruments. This $170,008.95 contract has a completion date of September 2, 2025 and will support the essential sequencing operations of NIAMS's Genomic Technology Section. Illumina is a manufacturer of genetic and genomic analysis solutions, and has previously been awarded prime contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to supply a range of Illumina sequencing systems and related consumables, services, and bioinformatics products. This contract award does not include any set-aside provisions.
Description
Illumina INC:1107104 [21-002812] - the genomic technology section within niams requests the purchase of sequencing reagent kits for our illumina novaseq 6000 and nextseq 550. These kits are extremely essential to continue the sequencing operation of
Quick answers
Who was awarded contract 75N92B21F02003?
75N92B21F02003 was awarded to Illumina, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on May 3, 2021.
How much is contract 75N92B21F02003 worth?
The government has obligated $170,009 on 75N92B21F02003.
Is contract 75N92B21F02003 an order under another contract?
Yes. 75N92B21F02003 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92B21F02003 competed?
The extent of competition for 75N92B21F02003 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award